ademetionine

This page covers all ademetionine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Protein-beta-aspartate methyltransferase, Phenylethanolamine N-methyltransferase, Protein arginine N-methyltransferase 1.

Targets

Protein-beta-aspartate methyltransferase, Phenylethanolamine N-methyltransferase, Protein arginine N-methyltransferase 1

Phase 3 pipeline (1)

• Donamet · Neuroscience
  Donamet works by inhibiting the enzyme Phenylethanolamine N-methyltransferase, which plays a role in the breakdown of certain neurotransmitters.

Patent intelligence

• ademetionine patent landscape — aggregated cliff calendar, attackable patents, originator estates